Discover

BTMD
biote Corp.
1.99
2 x 1.47
2 x 2.48
bid
ask
+
0.10
5.29%
2 @ 04:00 PM
1.99 +0.00 (0.00%)
Ytd-23.46%
1y-51.70%
1.87
day range
2.04
1.27
52 week range
4.75
Open1.87Prev Close1.89Low1.87High2.04Mkt Cap70.75M
Vol246.02KAvg Vol299.38KEPS0.43P/E4.63Forward P/E9.98
Beta0.94Short Ratio3.73Inst. Own64.60%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0550-d Avg2.14200-d Avg2.331yr Est9.95
Earning
DateForEstimateReportedSurprisesurprise %
2024-11-122024-090.090.330.24266.67%
2024-08-082024-060.090.140.0555.56%
2024-08-082024-060.09N/AN/AN/A
2024-05-072024-030.050.230.18360.00%
2024-05-072024-030.05N/AN/AN/A
2024-03-122023-120.08N/AN/AN/A
Upgrade / Downgrade
DateFirmActionFromTo
2024-12-16Craig-HallumUpgradeBuy
2024-03-13Roth MKMUpgradeBuyBuy
2024-02-20B. Riley SecuritiesUpgradeBuy
2024-02-01JefferiesUpgradeBuy
2024-01-18Truist SecuritiesUpgradeBuyBuy
2024-01-18Roth MKMUpgradeBuyBuy
Profile
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.
Insider Holder
DateNameRelationQuantityDescription
2023-01-08BEER MARC DDirector0.00Sale
2023-06-29CONE STEPHEN MARKDirector122.73KConversion of Exercise of derivative security
2023-07-04CONLON MARY ELIZABETHGeneral Counsel140.39KSale
2023-01-08HEYER ANDREW RDirector0.00Purchase
2024-05-20JACOBY DANA LYNNDirector50.97KConversion of Exercise of derivative security
2023-01-08KAMDAR SAMAR JAGATChief Financial Officer13.00KPurchase
Institution Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29325 Capital Llc4.55M26.33M14.32%
2024-09-29Bandera Partners LLC2.44M14.10M7.67%
2024-09-29Blackrock Inc.1.73M9.99M5.44%
2024-09-29Vanguard Group Inc1.42M8.21M4.47%
2024-09-29Wasatch Advisors LP1.39M8.06M4.39%
2024-09-29Dimensional Fund Advisors LP678.46K3.93M2.14%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Vanguard Total Stock Market Index Fund856.60K4.96M2.70%
2024-10-30iShares Russell 2000 ETF673.53K3.90M2.12%
2024-09-29Wasatch Micro-Cap Value Fund613.01K3.55M1.93%
2024-09-29RBB Fund Inc.- Boston Partners Small Cap Value Fd II493.86K2.86M1.56%
2024-09-29Vanguard Extended Market Index Fund342.07K1.98M1.08%
2024-08-30Fidelity Small Cap Index Fund270.54K1.57M0.85%